Natural killer receptor-mediated regulation of dendritic cell functions in chronic hepatitis C
自然杀伤受体介导的慢性丙型肝炎树突状细胞功能的调节
基本信息
- 批准号:16390207
- 负责人:
- 金额:$ 5.38万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Natural kilier (NK) cells are specialized lymphocytes that provide a first line of defense through their ability to kill pathogen-infected cells and transformed cells. The function of NK cells is regulated by a fine balance of inhibitory and activating signals, which are mediated by a diverse array of cell-surface receptors. We recently found that expression of the inhibitory receptor CD94/NKG2A is upregulated on NK cells in patients with chronic hapatitis C. HLA-E, a ligand for NKG2A, was expressed in all human hepatoma cell lines tested as well as non-transformed hepatocytes, but not in K562 cells, a classical NK-sensitive target. NK cells isolated from patients with chronic hepatitis C (HCV-NK) were less capable of killing hepatoma cells and of producing IFNγ in response to hepatoma cells than those from healthy donors, whereas there was no significant difference in NK responsiveness towards K562 cells. Of note is the finding that maturation and activation of monocyte-derived dendritic cells were negatively modulated in the presence of HCV-NK and hepatoma cells, which was restored by the addition of anti-NKG2A antibody during the coculture of HCV-NK and hepatoma cells. Research revealed that dendritic cells recognize danger signals from microorganisms by monitoring pathogen-associated molecular patterns via Toll-like receptors. Our findings have shed light on NK receptors as an important interface that transmits danger signals from abnormal cells to immune systems. Aberrant expression of CD94/NKG2A should have negative impact on innate resistance and subsequent adaptive immunity towards HCV-infected or transformed cells in chronic hepatitis C.
自然杀伤细胞(NK)是一种特殊的淋巴细胞,通过其杀死病原体感染细胞和转化细胞的能力提供第一道防线。NK细胞的功能由一系列不同的细胞表面受体介导的抑制和激活信号的精细平衡来调节。我们最近发现慢性丙型肝炎患者NK细胞表面抑制受体CD94/NKG2A的表达上调,NKG2A的配体HLAE在所有受试的人肝癌细胞系和未转化的肝细胞中都有表达,但在经典的NK敏感靶点K562细胞中不表达。从慢性丙型肝炎患者分离的NK细胞杀伤肝癌细胞的能力和产生干扰素γ的能力低于健康献血者,而NK细胞对K562细胞的反应性无显著差异。值得注意的是,单核细胞来源的树突状细胞的成熟和激活在存在丙型肝炎病毒-NK细胞和肝癌细胞的情况下受到负调控,在丙型肝炎病毒-NK细胞和肝癌细胞共培养过程中加入抗NKG2A抗体可以恢复这种调节。研究表明,树突状细胞通过Toll样受体监测病原体相关的分子模式,识别来自微生物的危险信号。我们的发现揭示了NK受体是将危险信号从异常细胞传递到免疫系统的重要接口。CD94/NKG2A的异常表达可能对慢性丙型肝炎患者对感染或转化的细胞的先天抵抗和随后的获得性免疫产生负面影响。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection
- DOI:10.4049/jimmunol.173.10.6072
- 发表时间:2004-11-15
- 期刊:
- 影响因子:4.4
- 作者:Jinushi, M;Takehara, T;Hayashi, N
- 通讯作者:Hayashi, N
Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses
- DOI:10.1053/j.gastro.2004.07.019
- 发表时间:2004-10-01
- 期刊:
- 影响因子:29.4
- 作者:Takehara, T;Tatsumi, T;Hayashi, N
- 通讯作者:Hayashi, N
Quick generation of fully mature dendritic cells from monocytes with OK432, low-doseprostanoid and interferon-α as potent immune enhancers.
使用 OK432、低剂量前列腺素和干扰素-α 作为有效的免疫增强剂,从单核细胞快速生成完全成熟的树突状细胞。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Sakakibara M;Takehara T;et al.
- 通讯作者:et al.
Viral covalently closed circular DNA in a non-transgenic mouse model for chronic hepatitis B virus replication
- DOI:10.1016/j.jhep.2005.07.030
- 发表时间:2006-02-01
- 期刊:
- 影响因子:25.7
- 作者:Takehara, T;Suzuki, T;Hayashi, N
- 通讯作者:Hayashi, N
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TAKEHARA Tetsuo其他文献
TAKEHARA Tetsuo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TAKEHARA Tetsuo', 18)}}的其他基金
Molecular mechanisms of acinar cell injury in acute pancreatitis
急性胰腺炎腺泡细胞损伤的分子机制
- 批准号:
24659364 - 财政年份:2012
- 资助金额:
$ 5.38万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Regulation of autophagy and its impact in the development and progression of hepatocellular cancer.
自噬的调节及其对肝细胞癌发生和进展的影响。
- 批准号:
23390197 - 财政年份:2011
- 资助金额:
$ 5.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Bcl-2 network and regulation of cell death in non-alcoholic steatohepatitis
Bcl-2网络与非酒精性脂肪性肝炎细胞死亡的调节
- 批准号:
21659188 - 财政年份:2009
- 资助金额:
$ 5.38万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Molecular mechanism of the ectodomain shedding of the NKG2D ligand MHC class I-related chain A in hepatocellular carcinoma and its therapeutic implication
肝癌中NKG2D配体MHC I类相关链A胞外域脱落的分子机制及其治疗意义
- 批准号:
20390208 - 财政年份:2008
- 资助金额:
$ 5.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular regulation of NK cell cytotoxicity fir human hepatocellular carcinoma
NK细胞对人肝细胞癌细胞毒性的分子调控
- 批准号:
18390216 - 财政年份:2006
- 资助金额:
$ 5.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Suppression of hepatocarcinogenesis by activating natural killer T cells
通过激活自然杀伤 T 细胞抑制肝癌发生
- 批准号:
14570468 - 财政年份:2002
- 资助金额:
$ 5.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
中国北方人群肺癌患者Cancer/Testis抗原表达谱绘制表位鉴定及功能性抗原特异性CTL制备研究
- 批准号:81673007
- 批准年份:2016
- 资助金额:54.0 万元
- 项目类别:面上项目
相似海外基金
Quantitative ultrasound to improve detection and diagnosis of liver cancer
定量超声改善肝癌的检测和诊断
- 批准号:
490038 - 财政年份:2023
- 资助金额:
$ 5.38万 - 项目类别:
Operating Grants
Modulating the immuno-metabolic interplay in liver cancer with cryoablation
通过冷冻消融调节肝癌的免疫代谢相互作用
- 批准号:
10647494 - 财政年份:2023
- 资助金额:
$ 5.38万 - 项目类别:
In vivo feasibility of a smart needle ablation treatment for liver cancer
智能针消融治疗肝癌的体内可行性
- 批准号:
10699190 - 财政年份:2023
- 资助金额:
$ 5.38万 - 项目类别:
TUMOUR-HOST INTERACTIONS IN LIVER CANCER OF CHILDHOOD AND ADULTS
儿童和成人肝癌中肿瘤与宿主的相互作用
- 批准号:
10100127 - 财政年份:2023
- 资助金额:
$ 5.38万 - 项目类别:
EU-Funded
The impact of sepsis-induced inflammation on pancreatic cancer liver metastasis
脓毒症引起的炎症对胰腺癌肝转移的影响
- 批准号:
10679730 - 财政年份:2023
- 资助金额:
$ 5.38万 - 项目类别:
Development of retroviral replicating vector-mediated liver-expressed iron-regulating peptide hormone, hepcidine gene therapy for esophageal cancer.
开发逆转录病毒复制载体介导的肝脏表达的铁调节肽激素、食道癌的铁碱基因疗法。
- 批准号:
23K08184 - 财政年份:2023
- 资助金额:
$ 5.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
3D Engineered Model of Microscopic Colorectal Cancer Liver Metastasis for Adjuvant Chemotherapy Screens
用于辅助化疗筛选的显微结直肠癌肝转移 3D 工程模型
- 批准号:
10556192 - 财政年份:2023
- 资助金额:
$ 5.38万 - 项目类别:
Engineering and preliminary safety assessment of an RNA trans-splicing therapeutic vector for liver cancer.
肝癌 RNA 反式剪接治疗载体的工程设计和初步安全性评估。
- 批准号:
10075525 - 财政年份:2023
- 资助金额:
$ 5.38万 - 项目类别:
Grant for R&D
Development of all-round combination immunotherapy for advanced liver cancer
晚期肝癌全方位联合免疫疗法的研发
- 批准号:
23H02886 - 财政年份:2023
- 资助金额:
$ 5.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identification of early postoperative recurrence of colorectal cancer liver metastases using ctDNA in exosome and L-EV
利用外泌体中的 ctDNA 和 L-EV 识别结直肠癌肝转移术后早期复发
- 批准号:
23K08182 - 财政年份:2023
- 资助金额:
$ 5.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




